Home › Post-COVID Conditions (Long COVID) › Minnesota
Post-COVID Conditions (Long COVID) clinical trials in Minnesota
6 studies for Post-COVID Conditions (Long COVID) are looking for participants at sites in Minnesota.
Randomized Double-Blind Placebo-Controlled Trial EValuating Baricitinib on PERSistent NEurologic and Cardiopulmonary Symptoms of Long COVID
- University of Minnesota, Minneapolis
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 25, 2026 · NCT06631287A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
- Mankato Clinic ( Site 3842), Mankato
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06667700Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen
- Research Site, Saint Paul
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 28, 2026 · NCT05624450Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study
- Mayo Clinic Rochester, Rochester
RecruitingPhase 3
All ages · All sexes · Updated Jun 23, 2026 · NCT03808922A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae
- Mayo Clinic Minnesota, Rochester
RecruitingObservational study
Ages 18 and older · All sexes · Updated May 7, 2026 · NCT06006884EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
- Childrens Hospitals and Clinics of Minnesota, Minneapolis
RecruitingPhase 3
Ages 0 to 17 · All sexes · Updated Jul 17, 2025 · NCT05261139From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.